USE OF A LACTOFERRIN ASSAY IN THE DIFFERENTIAL-DIAGNOSIS OF FEMALE GENITAL-TRACT INFECTIONS AND IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF BACTERIAL VAGINOSIS
Mf. Rein et al., USE OF A LACTOFERRIN ASSAY IN THE DIFFERENTIAL-DIAGNOSIS OF FEMALE GENITAL-TRACT INFECTIONS AND IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF BACTERIAL VAGINOSIS, Sexually transmitted diseases, 23(6), 1996, pp. 517-521
Background and Objectives: Lactoferrin has served as a marker for leuk
ocytes (polymorphonuclear neutrophils [PMN]) in clinical specimens. Go
al: To investigate the potential of a lactoferrin latex agglutination
test in the differential diagnosis of female genital infection. Study
Design: Lactoferrin was quantified in the vaginal discharge of women w
ith genital infections. Polymorphonuclear neutrophils were added to va
ginal discharge and observed over 8 hours. Results: Vaginal lactoferri
n titers were significantly elevated in women with trichomoniasis, can
didiasis, and bacterial vaginosis (BV). Using a lactoferrin titer of g
reater than or equal to 1:40, the assay has a sensitivity of 79.3% and
a specificity of 83.3% for the presence of trichomoniasis or bacteria
l vaginosis. Vaginal discharge from women with BV significantly destro
yed added PMN. Conclusions: Vaginal lactoferrin determinations may pro
vide a useful screen for inflammatory genital infections and identify
individuals who require additional diagnostic evaluation. The observed
absence of PMN in bacterial vaginosis may result from the destruction
of PMN in vaginal discharge rather than the absence of a primary infl
ammatory response.